Clinical studies recruiting near Cumberland

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Astellas Pharma Global Development, Inc. · NCT06779773 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · UPMC at Western Maryland Health System · Agendia · NCT03053193 A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Se
Phase 1/Phase 2 · Sanofi · NCT07215234 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · UPMC Western Maryland · NRG Oncology · NCT05174169 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · UPMC Western Maryland · Alliance for Clinical Trials in Oncology · NCT06876714 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · Kodiak Sciences Inc · NCT06990399 Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Phase 4 · Neurotech Pharmaceuticals · NCT06971939 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · UPMC Western Maryland · National Cancer Institute (NCI) · NCT06498635 A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Phase 2 · Vantage Biosciences Ltd · NCT06770933 RA-PRO PRAGMATIC TRIAL
Phase 3 · University of Alabama at Birmingham · NCT04692493 A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psori
Phase 4 · Klein & Associates, M.D., P.A. · Eli Lilly and Company · NCT06864026 Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · 4D Molecular Therapeutics · NCT07064759 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · UPMC Western Maryland · National Cancer Institute (NCI) · NCT06058377 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · UPMC Western Maryland · National Cancer Institute (NCI) · NCT05987241 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · UPMC Western Maryland · National Cancer Institute (NCI) · NCT05564377 Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Phase 3 · University of Pennsylvania · NCT05669833 Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (
Phase 2 · UPMC Western Maryland · National Cancer Institute (NCI) · NCT06126276 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · UPMC Western Maryland · SWOG Cancer Research Network · NCT06616584 A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 2 · Boehringer Ingelheim · NCT06962839 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Phase 1/Phase 2 · 4D Molecular Therapeutics · NCT05197270 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · UPMC Western Maryland · National Cancer Institute (NCI) · NCT04267848 A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Tre
Phase 4 · Genentech, Inc. · NCT04853251 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · UPMC Western Maryland · SWOG Cancer Research Network · NCT03851445 A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Se
Phase 2 · Janssen Research & Development, LLC · NCT06635148 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · UPMC Western Maryland · SWOG Cancer Research Network · NCT05642572 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · National Spine and Pain Centers · Stryker Instruments · NCT03072927 A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
Phase 2 · Clinical Res Collaborative · Novo Nordisk A/S · NCT07639021 Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Phase 3 · UMC Utrecht · NCT02735707 COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · EyePoint Pharmaceuticals, Inc. · NCT07449936 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2/Phase 3 · EyeBiotech Ltd. · NCT07440225

Look up another city

Look up another condition